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(39 ± 2 vs. 42 ± 2 %, P < 0.001), and increased plasma 
volume (P < 0.001). Resting plasma cortisol increased 
while plasma ACTH decreased following IT (P < 0.05), 
with no between-trial differences. Following IT, antigen-
stimulated whole blood culture production of IL-1α was 
higher in L-CHO than H-CHO (0.70 (95 % CI 0.52–0.95) 
pg/ml versus 0.33 (0.24–0.45) pg/ml, P < 0.01), as was pro-
duction of IL-1β (9.3 (95 % CI 7–10.4) pg/ml versus 6.0 
(5.0–7.8) pg/ml, P < 0.05). Circulating total leukocytes 
(P < 0.05) and neutrophils (P < 0.01) at rest increased fol-
lowing IT, as did neutrophil:lymphocyte ratio and percent-
age CD4+ lymphocytes (P < 0.05), with no between-trial 
differences.
Conclusion IT resulted in symptoms consistent with 
overreaching, although immunological changes were mod-
est. Higher carbohydrate intake was not able to alleviate 
physiological/immunological disturbances.
Keywords Overreaching · Cytokine · Lymphocyte · 
Interleukin · Cortisol · ACTH
Abbreviation
ACSM  American College of Sports Medicine
ACTH  Adrenocorticotropic hormone
H-CHO  High carbohydrate-supplemented condition
HRmax  Maximal heart rate
IFN-γ  Interferon gamma
IL  Interleukin
IT  Intensified training
L-CHO  Low carbohydrate-supplemented condition
PBS  Phosphate-buffered saline
TNF-α  Tumour necrosis factor alpha
Treg  Regulatory T cell
URTI  Upper respiratory tract infection
V˙CO2  Carbon dioxide production
Abstract 
Purpose To determine effects of intensified training (IT) 
and carbohydrate supplementation on overreaching and 
immunity.
Methods In a randomized, double-blind, crossover design, 
13 male cyclists (age 25 ± 6 years, V˙O2max 72 ± 5 ml/kg/
min) completed two 8-day periods of IT. On one occasion, 
participants ingested 2 % carbohydrate (L-CHO) bever-
ages before, during and after training sessions. On the sec-
ond occasion, 6 % carbohydrate (H-CHO) solutions were 
ingested before, during and after training, with the addi-
tion of 20 g of protein in the post-exercise beverage. Blood 
samples were collected before and immediately after incre-
mental exercise to fatigue on days 1 and 9.
Results In both trials, IT resulted in decreased peak power 
(375 ± 37 vs. 391 ± 37 W, P < 0.001), maximal heart rate 
(179 ± 8 vs. 190 ± 10 bpm, P < 0.001) and haematocrit 
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V˙E  Minute ventilation
V˙O2  Oxygen uptake
V˙O2max  Maximal oxygen uptake
Introduction
Overload is a key training principle used by athletes and 
coaches to improve physical performance. Periods of inten-
sified training (IT) are therefore commonly incorporated 
over the course of a training season. However, when high 
training load is combined with insufficient recovery and/or 
other stressors such as lack of sleep, psychological stress, 
environmental stress or inadequate energy intake, it can 
lead to a state of overreaching and place athletes at risk of 
developing symptoms of overtraining syndrome (Meeusen 
et al. 2013). The primary marker for the diagnosis of over-
reaching or overtraining syndrome is a reduction in sport-
specific performance. Functional overreaching results in 
acute fatigue and a short-term decrement in performance 
lasting a few days, typically followed by a subsequent 
supercompensation. Non-functional overreaching or over-
training, on the other hand, is associated with long-term 
performance decrements that can last from several weeks to 
months, or even years (Meeusen et al. 2013).
Upper respiratory infections are the most common medi-
cal complaints affecting athletes (Fricker et al. 2005; Reeser 
et al. 2003), with the occurrence being particularly high 
during times of intense training or competition (Nieman 
2000). Much anecdotal evidence also indicates increased 
upper respiratory infection incidence in athletes with symp-
toms of overtraining syndrome. This is not altogether sur-
prising, as previous studies have reported reduced salivary 
secretory immunoglobulin-A (Gleeson et al. 1995; Mackin-
non and Hooper 1994), reduced numbers of natural killer 
cells (Gleeson et al. 1995; Meyer et al. 2004) and CD3+ 
and CD4+ cells (Baj et al. 1994), impaired neutrophil func-
tion (Baj et al. 1994; Robson-Ansley et al. 2007), reduced 
glutamine/glutamate ratio (Coutts et al. 2007; Halson et al. 
2003; Parrybillings et al. 1992; Rowbottom et al. 1995) 
and elevated plasma concentrations of interleukin(IL)-6 
and creatine kinase at rest (Robson-Ansley et al. 2007) in 
response to IT. In addition, studies suggest that the capac-
ity of immune cells to produce cytokines in response to an 
immune challenge may be impaired (Baj et al. 1994; Lan-
caster et al. 2004; Morgado et al. 2012). Cytokines play a 
key, pleiotropic role in orchestrating the responses of lym-
phocytes, macrophages and other immune cells during 
an infection (Biron et al. 1999; Samuel 2001; Trinchieri 
1997). Disturbances to the profile of cytokine production 
in response to IT may therefore increase infection suscep-
tibility. Gleeson et al. (2011a, b) found that athletes with a 
high training load (≥11 h moderate–high-intensity training 
per week) had more than twice as many upper respiratory 
tract infections (URTI) episodes, alongside approximately 
threefold higher resting IL-2, IL-4 and IL-10 production 
in response to antigen challenge compared to athletes with 
a low training volume (<6 h per week). An elevated anti-
inflammatory response, and specifically increased IL-10 
production, appears to be a risk factor for URTI in athletes 
(Gleeson et al. 2012). IL-10 is primarily produced by lym-
phocytes and, in particular, regulatory T (Treg) cells (Glee-
son et al. 2011b); circulating numbers of Treg cells appear 
to be higher in physically active compared with sedentary 
individuals (Handzlik et al. 2013), but no studies to date 
have investigated changes in this cell population during IT.
Carbohydrate intake may play a role in the prevention of 
overreaching and alleviate associated immune disturbances 
(Achten et al. 2004; Halson et al. 2004; Costa et al. 2005), 
possibly via attenuation of the stress hormone response to 
exercise (Costa et al. 2005). Most competitive endurance 
athletes typically ingest some carbohydrate during pro-
longed bouts of training or competition. However, it is not 
clear whether increasing carbohydrate ingestion before, 
during and after exercise in line with American College 
of Sports Medicine (ACSM) guidelines (Rodriguez et al. 
2009) can provide additional protection against overreach-
ing and immune disturbances compared to more modest 
carbohydrate intakes in and around the exercise occasion.
The aim of the current study was therefore to determine 
the effects of 8 days of intensified cycling training with a 
self-selected diet supplemented with either low or high car-
bohydrate drinks before, during and after training sessions, 
on immunity and markers of overreaching in highly trained 
cyclists.
Methods
Subjects
Thirteen highly trained male cyclists provided their writ-
ten, informed consent to participate in the study, which was 
approved by the Loughborough University ethical advisory 
committee. Prior to the start of the study, participants com-
pleted a health screening questionnaire. Subjects could be 
included if they were between 18 and 35 years of age, had a 
maximal oxygen uptake (V˙O2max) of ≥64 mL/kg/min, had 
been actively competing in cycling for at least 2 years and 
were currently engaging in a minimum of 6 h of cycling 
training per week. Participants were also required to be cur-
rently healthy and without upper respiratory symptoms or 
use of any medication during the past 4 weeks. Exclusion 
criteria were: smoking, suffering from, or with a history of, 
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cardiac, hepatic, pulmonary, renal, neurological, haemato-
logical, psychiatric or gastrointestinal illness, or baseline 
haematological values (leukocyte and erythrocyte counts) 
outside the normal range. Baseline characteristics were 
as follows (mean ± SD): age 25 ± 6 years, body mass 
69.7 ± 6.3 kg, height 1.78 ± 0.03 m, body fat percent-
age 13.4 ± 4.1 %, and V˙O2max 72.2 ± 4.9 mL/kg/min, 
5.0 ± 0.5 L/min.
Study design
The study was conducted using a double-blind, placebo-
controlled, crossover design. Each participant completed 
two 8-day periods of intensified training in a randomized 
and counterbalanced order, separated by a 15-day washout 
period (Fig. 1). During one trial, participants were provided 
with high carbohydrate solutions to drink before, during 
and after every training session (H-CHO). In the other trial 
they were given a taste-matched low carbohydrate solution 
(L-CHO).
Baseline training
Prior to the start of the study, participants were asked 
to record all of their training for a minimum of 2 weeks. 
Session structure and duration, type of exercise, heart rate 
and power output data were uploaded to an online training 
diary (TrainingPeaks, Peaksware LLC, Colorado). These 
data were analysed to give a baseline total weekly number 
of hours of cycling and training volume at different intensi-
ties and used to calculate and prescribe individual training 
plans for each IT period.
Intensified training
During each 8-day IT period, participants were prescribed 
an individualized training plan with targets for training 
time, heart rate and power output set for every session. 
Heart rate and power targets were based on results from the 
initial V˙O2max test. These were adjusted accordingly for 
the second trial if performance in the V˙O2max test on day 1 
differed significantly from that in the first trial. During each 
IT period, total training volume was doubled compared 
to baseline training, and time spent at high intensity more 
than trebled, with high-intensity training (Table 1, Zones 
3+) comprising ~35 % of the total training time. Training 
was categorized into five heart rate zones.
All participants were prescribed two sessions per day, 
with every session including a high-intensity interval 
training component (Zones 3–5). In addition to maximal 
incremental tests, participants attended the laboratory for 
supervised training sessions on days 1, 2, 5, 6 and 8 of both 
trials.
All training was performed either out on the road or in 
the laboratory on the participant’s own bike equipped with 
a power meter (SRM PowerMeter Shimano DA7950 com-
pact, SRM International, Jülich, Germany) and mounted on 
a stationary turbo trainer to provide resistance. Heart rate 
and power output were recorded continuously for every ses-
sion with a sampling frequency of 4 Hz and stored on the 
SRM PowerControl 7. All training data were subsequently 
Fig. 1  Diagrammatic representation of the intensified training protocol
Table 1  Heart rate zones used for categorization of training intensity
Low intensity
 Zone 1 55–71 % HRmax
 Zone 2 72–81 % HRmax
High intensity
 Zone 3 82–87 % HRmax
 Zone 4 88–92 % HRmax
 Zone 5 >92 % HRmax
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uploaded to and analysed in an online training diary (Train-
ingPeaks, Peaksware LLC, Colorado). Participants were 
required to complete every session prescribed in their train-
ing plan to be included in the study. The two IT periods 
were separated by a 15-day washout, during which par-
ticipants were encouraged to take time to recover before 
returning to normal training. Participants were asked to 
continue recording and uploading training data during the 
washout period.
Nutritional intervention
For both trials, participants were provided with a specified 
volume and composition of drink before, during and after 
every training session (Table 2). Drinks ingested before and 
during exercise were taste matched, and participants were 
informed that the only difference in the nutritional inter-
vention between the two trials was that in one they would 
be provided with a recovery drink, whereas during the other 
the recovery drink would be replaced with a ‘recovery cap-
sule’ (containing only cellulose).
For a typical 2 h training session, this provided a total 
carbohydrate intake of 187.5 g in the H-CHO compared to 
52.4 g in L-CHO (an additional 17 g (~0.25 g/kg) protein 
was provided after exercise in the H-CHO group, with no 
protein received in the L-CHO group). The composition of 
the drinks provided in the H-CHO trial was chosen to con-
form with the current ACSM guidelines on recommended 
carbohydrate intake for endurance exercise (Rodriguez 
et al. 2009). Participants were asked to refrain from ingest-
ing any other sports nutrition products or nutritional sup-
plements for the duration of the study and were provided 
with a diet diary in which to record weighed food and fluid 
intake for 3 days prior to and throughout the course of each 
trial. Dietary analyses were performed using CompEat Pro 
software (Nutrition Systems, Banbury, England).
Maximal incremental test
On days 1 and 9 of each trial, subjects completed a con-
tinuous, incremental exercise test to volitional exhaustion 
on a magnetically braked cycle ergometer (IndoorTrainer, 
SRM International, Jülich, Germany) for determination 
of V˙O2max. Subjects arrived at the laboratory at 7:00 am 
following an overnight fast of at least 10 h and having 
abstained from caffeine for a minimum of 12 h. All tests 
were completed at the same time of the day to reduce inter- 
and intra-trial effects of diurnal variations in cytokine pro-
duction and plasma cortisol. The test began at 60 W with 
increments of 35 W every 3 min. Rating of perceived exer-
tion (RPE) was noted and heart rate measured continuously 
using short-range telemetry (Polar, Kempele, Finland). 
The expired gas was collected and analysed continuously 
using a computerized metabolic system with a mixing 
chamber (Moxus, AEI Technologies, Pennsylvania, USA) 
for determination of V˙E, V˙O2 and V˙CO2. Using these data, 
fat and carbohydrate oxidation rates were calculated using 
stoichiometric equations, assuming that protein oxidation 
throughout the test was negligible (Brouwer 1957). The gas 
analysers were calibrated with certified calibration gases 
of known concentrations before every test. The flow tur-
bine was calibrated before every test with a Micro Medi-
cal SM2125 series 3 L calibration syringe (CareFusion, 
Hoechberg, Germany). The same metabolic system with 
identical calibration routines was used for all performance 
tests. Subjects were asked to record and replicate as closely 
as possible their dietary intake during the 24 h leading up 
to each incremental test and were required to abstain from 
alcohol consumption 24 h previously.
Blood sampling
On days 1 and 9 of each trial, blood samples were collected 
at rest immediately before the start of the maximal exer-
cise test (PRE) and immediately after cessation of exercise 
(POST). On each occasion, a venous blood sample (11 mL) 
was obtained by venipuncture from an antecubital vein. 
Blood was collected into two vacutainer tubes (Becton–
Dickinson, Oxford, UK) containing either lithium heparin 
or K3EDTA as anticoagulant. Haematological analysis was 
immediately performed on the K3EDTA sample, as out-
lined below.
Table 2  Volumes and compositions of drinks provided before, during and after training sessions in H-CHO and L-CHO trials
Values in parentheses indicate carbohydrate content in grams
CHO carbohydrate, PRO protein
H-CHO L-CHO
Before exercise 118 mL 20 % CHO solution (24 g) 118 mL 2 % CHO solution (2.4 g)
During exercise 1 L per hour 6 % CHO solution (60 g/h) 1 L per hour 2 % CHO solution (20 g/h)
After exercise 1 × 500 mL 6 % CHO solution (30 g)
1 × 500 mL 2.7 % CHO/3.3 % PRO solution (13.5 g)
1 × 500 mL 2 % CHO solution (10 g)
1 × cellulose capsule (0 g)
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Blood cell counts
Blood samples in the K3EDTA vacutainer (4 mL) were 
used for determination of red blood cell concentration, 
haematocrit, haemoglobin and total and differential leuko-
cyte counts using an automated cell counter (Ac.TTM5diff 
haematology analyser, Beckman Coulter, High Wycombe, 
UK). The coefficient of variation for all measured variables 
in our laboratory was <2.0 %. Samples were analysed in 
duplicate and the average of both values entered into anal-
yses. Haematocrit and haemoglobin values were used to 
calculate changes in plasma volume using the equations of 
Dill and Costill (1974).
Plasma cortisol and ACTH
The remaining K3EDTA blood sample was centrifuged 
for 10 min at 1500g and 4 °C. Plasma was aliquoted and 
stored at −20 °C until analysis. Plasma concentrations of 
cortisol were determined using a commercially available 
solid phase competitive enzyme-linked immunosorbent 
assay (IBL International, Hamburg, Germany), with ana-
lytical sensitivity of 2.46 ng/mL and intra-assay coefficient 
of variation of <3.0 %. Plasma concentrations of ACTH 
were determined using a commercially available two-site 
enzyme-linked immunosorbent assay (Biomerica, Califor-
nia), with analytical sensitivity of 0.22 pg/mL and intra-
assay coefficient of variation of <6.0 %. Plates were read 
on a microtitre plate reader at 450 nm. All samples were 
assayed in duplicate.
Antigen‑stimulated cytokine production
Stimulated whole blood culture production of IFN-γ, 
TNF-α, IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8 and IL-10 was 
determined as follows: for each sample, 0.25 mL heparin-
ized whole blood was added to 0.75 mL RPMI medium 
(Sigma Chemicals, Poole, UK) with no added stimulant or 
stimulant at a dilution of 1:2000. The stimulant used was 
a commercially available multi-antigen vaccine containing 
diphtheria, tetanus, acellular pertussis, poliomyelitis and 
Haemophilus influenzae type b antigens (Pediacel vaccine, 
Sanofi Pasteur, Maidenhead, UK). The whole blood culture 
was then incubated for 24 h at 37 °C and 5 % CO2. Fol-
lowing centrifugation for 4 min at 13,000g in a microcen-
trifuge, the supernatants were collected and stored frozen 
at −20 °C until analysis. Cytokine concentrations were 
determined with an Evidence Investigator System using the 
cytokine biochip array EV 3623 (Randox, County Antrim, 
UK). The intra-assay coefficient of variation was <10 % for 
all measured cytokines. The unstimulated values were then 
subtracted from stimulated values to isolate cytokine pro-
duction specifically in response to the antigen stimulation 
and account for plasma concentrations and spontaneous 
production during the culture period.
Lymphocyte subsets
Fluorescent-conjugated monoclonal antibodies were used to 
identify specific cell surface markers (CD4, CD25, CD127) 
via four colour flow cytometry (FACS-Calibur, Becton–
Dickinson, Oxford, UK) with CellQuest analysis software 
(Becton–Dickinson Biosciences, Oxford, UK). Briefly, 10 
μL of human regulatory T cell cocktail (Becton–Dickin-
son Biosciences, Oxford, UK) was added to 120 μL hep-
arinized whole blood and incubated in the dark for 20 min 
on ice. Erythrocytes were then lysed by adding 1.5 mL of 
lysis solution (FACS lysis buffer, Becton–Dickinson Bio-
sciences). The sample was subsequently incubated for 
a further 10 min, before centrifugation at 1500g and 4 °C 
for 6 min. The supernatant was aspirated and the cells re-
suspended in phosphate-buffered saline solution (PBS) con-
taining 0.1 % bovine serum albumin and 2 mM EDTA. The 
mixture was centrifuged for a further 6 min at 1600g, the 
supernatant aspirated and the cells re-suspended in 400 μL 
PBS. Forward-scatter versus side-scatter plots were used to 
gate lymphocytes based on size and density, with 50,000 
lymphocyte events acquired per analysis. CD4+ lympho-
cytes were further gated to identify CD25+ cells, and those 
that were also CD127low/−. This was based on the finding 
that CD127 expression inversely correlated with FoxP3 (Liu 
et al. 2006) and can therefore be used to identify Treg cells. 
Values obtained represented a percentage of total lympho-
cytes for CD4+ CD25+ CD127low/−(Treg cells). Absolute 
values for CD4 + CD25 + CD127low/− cells were calculated 
based on the total lymphocyte count obtained previously via 
the automated cell counter. This process was also repeated 
to determine CD4+ and CD4+ CD25+ cell counts.
Statistical analysis
Data are presented as mean ± standard deviation (SD) 
unless otherwise stated. All statistical analyses were per-
formed using IBM SPSS Statistics 22.0. The Shapiro–Wilk 
test was used to determine whether data were normally 
distributed. A two-way repeated measures analysis of vari-
ance was used to determine whether there were significant 
differences between L-CHO and H-CHO trials before and 
after intensified training. A post hoc test with Bonferroni 
correction for multiple comparisons was used to determine 
the location of variance. Variables found to be significantly 
non-normal were log transformed prior to analysis and are 
presented as back-transformed geometric mean with 95 % 
confidence interval (CI). Based on the results of Mauch-
ly’s sphericity test, Greenhouse–Geisser corrections were 
applied for epsilon <0.75 and Huynd–Feldt corrections for 
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epsilon >0.75 where violations of sphericity were identified. 
Statistical significance was accepted at the P < 0.05 level.
Results
During the 8-day IT period, total training volume 
was increased from 9.3 ± 2.4 h/week at baseline, to 
23.5 ± 3.4 h/week, with high-intensity training (Zones 
3–5) increased from 2.6 ± 2.5 to 6.5 ± 4.0 h/week, with 
no differences between trials. During the 15-day wash-
out period between the two trials, participants returned to 
their baseline level of training. Over the 8-day IT period, 
participants completed 24.3 ± 3.3 MJ of cycling, with 
no significant difference between the trials. Total daily 
energy intake was significantly lower in L-CHO compared 
to H-CHO (14.7 ± 2.7 vs. 17.4 ± 3.2 MJ/d, P < 0.001). 
This difference was primarily due to lower carbohydrate 
intake in L-CHO (505 ± 107 vs. 679 ± 105 g/d, P < 0.001; 
7.2 ± 1.6 vs. 9.7 ± 1.5 g/kg/d, P < 0.05). However, in both 
groups, participants remained relatively weight stable, with 
a mean body mass change of +0.17 ± 1.14 kg in H-CHO 
and −0.55 ± 0.92 kg in L-CHO, with no significant differ-
ence between the two conditions (P = 0.144).
There was no change in V˙O2max following IT. However, 
in both L-CHO and H-CHO trials, IT resulted in decreased 
peak power in the maximal incremental exercise test com-
pared to baseline (375 ± 37 vs. 391 ± 37 W, main effect 
of IT P = 0.001) (Fig. 2), reduced maximal heart rate 
(179 ± 8 vs. 190 ± 10 bpm, main effect of IT P < 0.001), 
reduced haematocrit (39 ± 2 vs. 42 ± 2 %, main effect of 
IT P < 0.001) and a 14 ± 10 % increase in plasma volume 
at rest (PV) (main effect of IT P < 0.001) (Table 3), with no 
significant differences between trials.
Circulating total leukocytes and neutrophils at rest were 
increased with IT (P < 0.01, Table 4), as was the percent-
age of lymphocytes that were CD4+ (29 ± 6 vs. 26 ± 7 %, 
main effect of IT P < 0.05), with no difference between 
trials. Seven of the 13 participants had somewhat lower 
than normal numbers of CD4+ cells (<0.5 × 109 cells and 
<30 % of total lymphocytes) at baseline. The exercise-
induced increase in CD4+ cells was significantly reduced 
following IT (0.10 ± 0.14 × 109 vs. 0.19 ± 0.11 × 109, 
Fig. 2  Percentage change in 
peak power achieved during the 
incremental, maximal exercise 
test for each participant fol-
lowing the intensified train-
ing period with L-CHO and 
H-CHO. Dashed line indicates 
significant group mean change 
(P < 0.01)
Table 3  Haematological variables and plasma volume changes 
before and after acute maximal exercise, and before and after the 
8-day intensified training intervention
Data are mean ± SD
RBC red blood cell count, PV plasma volume, Hb haemoglobin, HCT 
haematocrit
* Significant effect of acute maximal exercise (P < 0.001), † sig-
nificantly different from the same time point pre-intensified training 
(P < 0.001)
8 days intensified training
Pre IT Post IT
Pre-exercise Post-exercise Pre-exercise Post-exercise
RBC (×109/L)
 H-CHO 4.60 ± 0.22 4.87 ± 0.28* 4.25 ± 0.19† 4.47 ± 0.23†*
 L-CHO 4.60 ± 0.16 4.87 ± 0.16* 4.29 ± 0.23† 4.52 ± 0.23†*
Hb (g/dL)
 H-CHO 14.3 ± 0.8 15.1 ± 0.9* 13.2 ± 0.8† 13.9 ± 0.9†*
 L-CHO 14.1 ± 0.8 14.9 ± 0.9* 13.0 ± 0.8† 13.6 ± 0.9†*
HCT (%)
 H-CHO 41.9 ± 2.4 45.0 ± 2.7* 39.0 ± 1.7† 41.3 ± 1.8†*
 L-CHO 42.0 ± 1.3 45.1 ± 1.7* 39.2 ± 2.0† 41.7 ± 2.0†*
PV (% of baseline)
 H-CHO 100 ± 0 89 ± 4* 114 ± 11† 104 ± 12†*
 L-CHO 100 ± 0 90 ± 5* 114 ± 10† 104 ± 9†*
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main effect of IT P < 0.01) with no significant differ-
ence between trials. There were no significant changes 
in the numbers of CD24+ CD25+ CD127low/−Treg cells 
following intensified training in either trial. Resting 
neutrophil:lymphocyte ratio was significantly increased 
following IT (Fig. 3, main effect of IT P < 0.05) with no 
significant difference between trials.
Resting plasma ACTH was lower following IT (61 (95 % 
CI 46–82) pg/mL vs. 78 (57–107) pg/mL, main effect of 
IT P < 0.01), while resting plasma cortisol concentration 
was increased (1037 (95 % CI 648–1661) nmol/L vs. 722 
(508–1025) nmol/L, main effect of IT P < 0.05) (Fig. 4). 
There was no significant effect of IT on the exercise-induced 
change in ACTH or cortisol, nor were there any significant 
differences between L-CHO and H-CHO in either hormone. 
Following IT, the production of IL-1α at rest in response 
to antigen challenge was higher in L-CHO compared to 
H-CHO (0.70 (95 % CI 0.52–0.95) pg/mL vs. 0.33 (0.24–
0.45) pg/ml, interaction effect P < 0.01), as was production 
of IL-1β (9.3 (95 % CI 7–10.4) pg/mL vs. 6.0 (5.0–7.8) 
pg/ml, interaction effect P < 0.05) (Fig. 5). Production of 
TNFα in response to antigen challenge also tended to be 
higher in L-CHO post-IT (P = 0.063). Antigen-stimulated 
production of other measured cytokines (IL-2, IL-4, IL-6, 
IL-8, IFN-γ) was not significantly altered by IT and did not 
differ between trials. All of the measured haematological 
and immunological variables were significantly increased 
immediately following acute maximal exercise (main effect 
of acute exercise P < 0.05) with no difference between trials.
Submaximal fat oxidation during the first five stages of 
the incremental test was significantly increased following 
IT (Fig. 6, main effect of IT P < 0.01), with this increase 
being greater in L-CHO (L-CHO: 0.51 ± 0.17 pre IT to 
0.81 ± 0.14 g/min post-IT vs. H-CHO: 0.58 ± 0.17 pre-IT 
to 0.77 ± 0.14 g/min post-IT, interaction effect P < 0.05). 
The workload at which maximal fat oxidation occurred was 
also increased following IT (226 ± 45 vs. 181 ± 41 W, main 
effect of IT P < 0.01) with no difference between trials.
Table 4  Leukocyte counts 
before and after acute maximal 
exercise, and before and after 
8 days of intensified training in 
L-CHO and H-CHO trials
Data are mean ± SD. Cell counts are corrected for changes in plasma volume
WBC total white blood cells, NEUT neutrophils, MONO monocytes, LYMPH lymphocytes, CD4+ lympho-
cytes expressing CD4 (T helper), CD4+ CD25+ lymphocytes expressing CD4 and CD25, CD4+ CD25+ 
CD127low/−lymphocytes expressing CD4 and CD25, but not CD127 (T regulatory)
* Significant effect of acute maximal exercise (P < 0.01), † significant difference from the same time point 
pre-intensified training (P < 0.01), # significant difference from L-CHO at the same time point (P < 0.05)
8 days intensified training
Pre-training Post-training
Pre-exercise Post-exercise Pre-exercise Post-exercise
WBC
 HCHO 5.30 ± 0.85 8.34 ± 1.49* 5.99 ± 1.00† 9.14 ± 1.70 *†
 LCHO 5.43 ± 0.93 7.93 ± 1.27* 5.92 ± 0.94† 8.31 ± 1.17 *†
NEUT
 HCHO 2.45 ± 0.49 3.17 ± 0.75* 2.93 ± 0.78† 3.99 ± 1.08 *†
 LCHO 2.58 ± 0.69 3.26 ± 0.77* 3.00 ± 0.78† 3.74 ± 0.81*†
MONO
 HCHO 0.51 ± 0.12 0.75 ± 0.22* 0.59 ± 0.15 0.89 ± 0.33*
 LCHO 0.53 ± 0.13 0.72 ± 0.18* 0.55 ± 0.14 0.75 ± 0.21*
LYMPH
 HCHO 2.17 ± 0.61 4.08 ± 1.07*# 2.26 ± 0.65 4.03 ± 0.98*#
 LCHO 2.12 ± 0.47 3.65 ± 0.66* 2.17 ± 0.47 3.53 ± 0.95*
CD4+
 HCHO 0.55 ± 0.21 0.77 ± 0.23*# 0.58 ± 0.20 0.71 ± 0.20*†#
 LCHO 0.54 ± 0.20 0.69 ± 0.23* 0.58 ± 0.20 0.65 ± 0.18*†
CD4+ CD25+
 HCHO 0.14 ± 0.04 0.22 ± 0.07* 0.14 ± 0.05 0.19 ± 0.05*
 LCHO 0.14 ± 0.05 0.18 ± 0.06* 0.13 ± 0.04 0.16 ± 0.05*
CD4+ CD25+ CD127low/−
 HCHO 0.05 ± 0.02 0.06 ± 0.03* 0.05 ± 0.02 0.06 ± 0.02*
 LCHO 0.05 ± 0.02 0.06 ± 0.02* 0.05 ± 0.02 0.05 ± 0.02*
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Discussion
The main finding of the current study is that an 8-day 
period of IT in highly trained cyclists induces some 
immunological, haematological, physiological and exer-
cise-related changes consistent with the symptoms of 
overreaching. However, carbohydrate supplementation in 
and around the exercise training occasion, in addition to 
Fig. 3  Change in 
neutrophil:lymphocyte ratio 
for each participant following 
intensified training with L-CHO 
and H-CHO. Dashed line 
indicates significant group mean 
change (P < 0.05)
Fig. 4  Resting plasma cortisol (a) and ACTH (b) following inten-
sified training. Values are mean ± 95 % CI. †Significant difference 
from pre-intensified training, P < 0.05. Corrected for change in 
plasma volume
Fig. 5  Resting antigen-stimulated production of interleukin-1α (a) 
and interleukin-1β (b) by whole blood culture before and after inten-
sified training with L-CHO and H-CHO. Values are mean ± 95 % CI. 
#Significant difference between L-CHO and H-CHO (P < 0.05)
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a high carbohydrate-containing diet (>7 g CHO/kg/day), 
did not appear to reduce the associated maximal power 
output decrement or ameliorate hormonal and immuno-
logical disturbances. This is in agreement with Snyder et al. 
(1995), who found that even when muscle glycogen was 
maintained via carbohydrate supplementation, competitive 
cyclists still displayed symptoms of overtraining follow-
ing 15 days of IT. In contrast, Achten et al. (2004) found 
that an increase in dietary carbohydrate from 5.4 to 8.5 g 
CHO/kg/day better maintained physical performance in 
runners undergoing a period of IT, reducing the symptoms 
of overreaching. Similarly, Costa et al. (2005) found that 
consumption of a very high carbohydrate diet (12 g CHO/
kg/day) during IT attenuated cortisol release and increased 
salivary secretory immunoglobulin-A concentration com-
pared to a self-selected, and more moderate, CHO intake 
of 5.9 g/kg/day. Halson et al. (2004) found that inges-
tion of a high carbohydrate beverage before, during and 
after training sessions over the course of an 8-day period 
of intensified cycling training better maintained perfor-
mance and reduced symptoms of overreaching compared 
to a low carbohydrate placebo (9.4 vs. 6.4 g/kg/day). How-
ever, in the current study, total daily carbohydrate intake 
in the control group was higher than in these studies at 7.2 
g/kg/day, a daily amount classed as ‘high’ in the Interna-
tional Olympic Committee’s latest consensus on sports 
nutrition (Burke et al. 2011). It is possible that this intake 
was already sufficient to provide some protection against 
immunological disturbances and other symptoms of over-
reaching. Another possible explanation is differences in 
training during the IT period. Compared with the study 
of Halson et al. (2004), participants in the current study 
completed a greater total volume of cycling (23.5 vs. 15.3 
h/week), but less high-intensity training (6.5 vs. 10.5 
h/week). Since muscle glycogen utilization is related to 
exercise intensity (Saltin and Karlsson 1971), it is possible 
to speculate that the lower number of hours of high-inten-
sity training in the current study may have resulted in lower 
glycogen depletion, and that CHO supplementation was 
therefore less critical in maintaining performance. In addi-
tion, participants in the current study were highly trained, 
with greater aerobic capacity than in previous studies, 
and may therefore have been more resilient to detrimental 
effects of the IT period. There was high inter-individual 
variation in the magnitude of the performance change fol-
lowing the IT period, with this ranging from −13 to +4 % 
across both trials. As such, for some of these well-trained 
athletes, the prescribed training load does not appear to 
have been sufficient to induce a true state of overreach-
ing. The fact that some individuals appear better able to 
tolerate IT periods than others is an important considera-
tion for coaches and practitioners, and highlights the need 
for individualised training programmes. The IT resulted in 
a marked reduction in resting haematocrit, haemoglobin 
and red blood cell concentration, likely primarily indica-
tive of a pronounced plasma volume expansion. It is well 
reported that physical training stimulates an increase in 
plasma volume (Convertino 1991) and it is likely that the 
changes observed in the current study are primarily indica-
tive of adaptation rather than overreaching. However, it is 
also possible that these changes were due, at least in part, 
to changes in red cell destruction or production as a result 
of IT. Indeed, strenuous endurance exercise has been asso-
ciated with increased intravascular haemolysis, due to oxi-
dative damage to red blood cells (Smith 1995).
Whether or not the changes in immune variables 
observed in the current study following IT might make 
athletes more susceptible to URTI is not clear. The 
~315 nmol/L increase in resting plasma cortisol may have 
negative implications for host defence, particularly since 
mean concentration at baseline was already towards the 
upper end of the normal range. Several studies have inves-
tigated the effect of IT on plasma cortisol concentrations, 
with the majority reporting no significant change in resting 
plasma cortisol following IT (Hooper et al. 1993; Mackin-
non et al. 1997; Urhausen et al. 1998). It is possible that 
the increase observed in the current study, along with ele-
vations in circulating leukocytes, neutrophils, CD4+ lym-
phocytes and neutrophil:lymphocyte ratio, may be only a 
transient effect caused by incomplete recovery from the 
previous exercise bout ~13 h earlier.
Handzlik et al. (2013) recently reported that endur-
ance trained athletes with a high training load (~15 
h/wk) had a significantly higher proportion of regulatory 
Fig. 6  Average fat oxidation during the first five stages (60–235 W) 
of the incremental test before and after intensified training in L-CHO 
and H-CHO trials. Values are mean + SD. *Significant difference 
from pre-intensified training in both trials, P < 0.01. #Significant 
interaction effect, P < 0.05
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T cells as a percentage of total lymphocytes and higher 
antigen-stimulated in vitro IL-10 production compared 
with sedentary individuals. However, in the current study, 
there was no significant effect of IT on absolute or rela-
tive numbers of Treg cells or antigen-stimulated IL-10 
production, suggesting that these variables are not altered 
by short-term increases in training load in individuals 
already training ~9 h/wk. However, antigen-stimulated 
production of both IL-1α and IL-1β was both reduced 
following IT in H-CHO and increased following IT in 
L-CHO. Type 1 cytokines, such as IL-1, promote cel-
lular immunity by stimulating the functional activity of 
T cytotoxic cells, natural killer cells and activated mac-
rophages (Gleeson et al. 2013). Reduced production of 
these cytokines in response to an immune challenge may 
therefore have negative implications for host defence. 
Similar to the results observed for the H-CHO trial, Mor-
gado et al. (2012) reported impaired production of IL-1β 
from dendritic cells and monocytes in swimmers follow-
ing IT. However, that IL-1α and IL-1 β production should 
be increased following IT in L-CHO appears counterin-
tuitive, and further research is necessary to corroborate 
these findings. Nevertheless, it is clear that increasing 
carbohydrate intake during exercise, from 20 to 60 g/h, 
does not provide any additional benefit in preserving the 
measured immune parameters during IT in this cohort 
of highly trained cyclists. In fact, since neither maximal 
power output nor immunity was better maintained with a 
high carbohydrate intake, and increases in fat oxidation 
were lower, it could be argued that ingesting a moderate 
(~20 g/h) carbohydrate dose during short-term IT may be 
more advantageous than a higher carbohydrate dose, at 
least when athletes already have a high daily intake of 
dietary carbohydrate (>7 g CHO/kg/day). This intake 
during exercise appears sufficient to help prevent large 
maximal power output decrements and preserve immu-
nity, while facilitating greater adaptation in terms of fat 
oxidation. Whether this improved capacity to oxidize fat 
has subsequent performance benefits once recovery from 
IT is complete is unknown.
The mean maximal oxygen uptake of participants in the 
current study was 72.2 mL/kg/min, and to our knowledge, 
no previous study has attempted to intentionally overreach 
such highly endurance trained athletes. The current data 
indicate that these athletes are relatively robust to increases 
in training load and can tolerate multiple consecutive days 
of IT without large reductions in maximal power out-
put or severe immune disturbances. However, since many 
of the participants had lower than expected numbers of 
CD4+ cells and higher than expected plasma cortisol 
already at baseline, it is possible that their habitually high 
training loads may already be associated with some mild 
immunodepression.
The fact, that participants consumed an otherwise self-
selected diet may be considered a limitation of the current 
study. However, previous studies have already established 
that increasing total daily carbohydrate intake can alleviate 
the symptoms of overreaching (Achten et al. 2004; Costa 
et al. 2005). In contrast, we wished to determine whether or 
not it is possible to preserve performance and immunity dur-
ing intensified training merely by manipulating carbohydrate 
intake in and around training sessions in athletes otherwise 
consuming a “normal” moderate–high carbohydrate diet.
It should be noted that, since the intervention beverages 
were not isocaloric, trials differed not only in carbohydrate 
intake but also in total energy intake, as well as in the pro-
tein content of the post-exercise recovery drinks. However, 
within the range tested in the current study, neither of these 
appears to influence the responses to IT. The lack of a sig-
nificant difference in weight change between trials, despite 
a difference in energy intake, may indicate limited validity 
of food diaries. Alternatively, it is possible to speculate that 
participants may have felt more tired and therefore reduced 
their general physical activity levels when on the L-CHO 
trial, despite no differences observed between trials in work 
done during the training sessions themselves.
Conclusion
Eight days of IT results in a number of changes consist-
ent with the symptoms of short-term overreaching in highly 
trained cyclists, although both immunological and physi-
ological changes are relatively modest. When ingesting 
an otherwise self-selected diet, a high carbohydrate intake 
immediately before, during and after training sessions was 
not able to better maintain maximal power output, or alle-
viate physiological/immunological disturbances compared 
to a moderate carbohydrate intake. The results also high-
light the importance of considering plasma volume changes 
when interpreting results from training studies, since even 
highly trained individuals demonstrate a pronounced 
plasma volume expansion following just 8 days of IT.
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